Clinical Trial

Italian Registry of Allergen ImmunoTherapy

Study acronym: RIAIT
Recruiting
View on ClinicalTrials.gov →
Summary
RIAIT (Italian Registry of Allergy Immunotherapy) is a multicenter observational study that aims to prospectively collect the most extensive data available on Italian patients using AIT for respiratory allergies (rhinoconjunctivitis and/or asthma) in a real-life context, through a network of allergy centers with specific interest and expertise in the management of allergic respiratory patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-05; most recent amendment 2025-03-03.
Trial Details
NCT Number NCT06499480
Lead Sponsor Società Italiana di Allergologia, Asma e Immunologia Clinica
Collaborators: Società Italiana di Allergologia e Immunologia Pediatrica (SIAIP)
Conditions Allergic Respiratory Disease
Enrollment 5,000 participants
Start Date 2024-05-01
Primary Completion 2035-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-06